-
Je něco špatně v tomto záznamu ?
Standard error of measurement and smallest detectable change of the Sarcopenia Quality of Life (SarQoL) questionnaire: An analysis of subjects from 9 validation studies
A. Geerinck, V. Alekna, C. Beaudart, I. Bautmans, C. Cooper, F. De Souza Orlandi, J. Konstantynowicz, B. Montero-Errasquín, E. Topinková, M. Tsekoura, JY. Reginster, O. Bruyère,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, validační studie
Grantová podpora
MC_U147585819
Medical Research Council - United Kingdom
MC_UP_A620_1014
Medical Research Council - United Kingdom
MC_UU_12011/1
Medical Research Council - United Kingdom
G0400491
Medical Research Council - United Kingdom
MC_U147585824
Medical Research Council - United Kingdom
NLK
Directory of Open Access Journals
od 2006
Free Medical Journals
od 2006
Public Library of Science (PLoS)
od 2006
PubMed Central
od 2006
Europe PubMed Central
od 2006
ProQuest Central
od 2006-12-01
Open Access Digital Library
od 2006-10-01
Open Access Digital Library
od 2006-01-01
Open Access Digital Library
od 2006-01-01
Medline Complete (EBSCOhost)
od 2008-01-01
Nursing & Allied Health Database (ProQuest)
od 2006-12-01
Health & Medicine (ProQuest)
od 2006-12-01
Public Health Database (ProQuest)
od 2006-12-01
ROAD: Directory of Open Access Scholarly Resources
od 2006
- MeSH
- kvalita života * MeSH
- lidé středního věku MeSH
- lidé MeSH
- průzkumy a dotazníky * MeSH
- sarkopenie patologie MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- validační studie MeSH
OBJECTIVES: The Sarcopenia Quality of Life (SarQoL) questionnaire, a sarcopenia-specific patient-reported outcome measure, evaluates quality of life with 55 items. It produces 7 domain scores and 1 overall quality of life score, all between 0 and 100 points. This study aims to contribute to the interpretation of the SarQoL scores by calculating the standard error of measurement (SEM) and smallest detectable change (SDC) in a sample of subjects from 9 studies. METHODS: Subjects from 9 studies (conducted in Belgium, Brazil, Czech Republic, England, Greece, Lithuania, Poland and Spain) were included. The SEM, a measure of the error in the scores that is not due to true changes, was calculated by dividing the standard deviation of the difference between test and retest scores (SDdiff) by √2. The SDC, defined as change beyond measurement error, was calculated by multiplying SDdiff by 1.96. Bland-Altman plots were assessed for the presence of systematic errors. RESULTS: A total of 278 sarcopenic subjects, aged 77.67 ± 7.64 years and 61.5% women, were included. The SEM for the overall SarQoL score ranged from 0.18 to 4.20 points for the individual studies, and was 2.65 points when all subjects were analyzed together. The SDC for the overall score ranged from 0.49 to 11.65 points for the individual studies, and was 7.35 points for all subjects. The Bland-Altman plots revealed no systematic errors in the questionnaire. CONCLUSION: This study shows that, for individual subjects, a change in overall quality of life of at least 7.35 points (on a scale from 0 to 100) would have to be observed to confirm that a true change, beyond measurement error, has occurred. It also demonstrated that the SarQoL questionnaire is a precise instrument, with the observed scores within less than 3 points of the theoretical "true score".
Department of Geriatrics University Hospital Ramón y Cajal Madrid Spain
Department of Gerontology Federal University of São Carlos São Carlos SP Brazil
Faculty of Medicine Vilnius University Vilnius Lithuania
Frailty in Aging Research Group Vrije Universiteit Brussel Brussels Belgium
MRC Environmental Epidemiology Unit Southampton General Hospital Southampton United Kingdom
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20006412
- 003
- CZ-PrNML
- 005
- 20200518132628.0
- 007
- ta
- 008
- 200511s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1371/journal.pone.0216065 $2 doi
- 035 __
- $a (PubMed)31034498
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Geerinck, Anton $u World Health Organization Collaborating Center for Public Health Aspects of Musculoskeletal Health and Ageing, Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium.
- 245 10
- $a Standard error of measurement and smallest detectable change of the Sarcopenia Quality of Life (SarQoL) questionnaire: An analysis of subjects from 9 validation studies / $c A. Geerinck, V. Alekna, C. Beaudart, I. Bautmans, C. Cooper, F. De Souza Orlandi, J. Konstantynowicz, B. Montero-Errasquín, E. Topinková, M. Tsekoura, JY. Reginster, O. Bruyère,
- 520 9_
- $a OBJECTIVES: The Sarcopenia Quality of Life (SarQoL) questionnaire, a sarcopenia-specific patient-reported outcome measure, evaluates quality of life with 55 items. It produces 7 domain scores and 1 overall quality of life score, all between 0 and 100 points. This study aims to contribute to the interpretation of the SarQoL scores by calculating the standard error of measurement (SEM) and smallest detectable change (SDC) in a sample of subjects from 9 studies. METHODS: Subjects from 9 studies (conducted in Belgium, Brazil, Czech Republic, England, Greece, Lithuania, Poland and Spain) were included. The SEM, a measure of the error in the scores that is not due to true changes, was calculated by dividing the standard deviation of the difference between test and retest scores (SDdiff) by √2. The SDC, defined as change beyond measurement error, was calculated by multiplying SDdiff by 1.96. Bland-Altman plots were assessed for the presence of systematic errors. RESULTS: A total of 278 sarcopenic subjects, aged 77.67 ± 7.64 years and 61.5% women, were included. The SEM for the overall SarQoL score ranged from 0.18 to 4.20 points for the individual studies, and was 2.65 points when all subjects were analyzed together. The SDC for the overall score ranged from 0.49 to 11.65 points for the individual studies, and was 7.35 points for all subjects. The Bland-Altman plots revealed no systematic errors in the questionnaire. CONCLUSION: This study shows that, for individual subjects, a change in overall quality of life of at least 7.35 points (on a scale from 0 to 100) would have to be observed to confirm that a true change, beyond measurement error, has occurred. It also demonstrated that the SarQoL questionnaire is a precise instrument, with the observed scores within less than 3 points of the theoretical "true score".
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a kvalita života $7 D011788
- 650 _2
- $a sarkopenie $x patologie $7 D055948
- 650 12
- $a průzkumy a dotazníky $7 D011795
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a validační studie $7 D023361
- 700 1_
- $a Alekna, Vidmantas $u Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
- 700 1_
- $a Beaudart, Charlotte $u World Health Organization Collaborating Center for Public Health Aspects of Musculoskeletal Health and Ageing, Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium.
- 700 1_
- $a Bautmans, Ivan $u Frailty in Aging Research Group, Vrije Universiteit Brussel, Brussels, Belgium.
- 700 1_
- $a Cooper, Cyrus $u MRC Environmental Epidemiology Unit, Southampton General Hospital, Southampton, United Kingdom.
- 700 1_
- $a De Souza Orlandi, Fabiana $u Department of Gerontology, Federal University of São Carlos, São Carlos, SP, Brazil.
- 700 1_
- $a Konstantynowicz, Jerzy $u Department of Pediatric Rheumatology, Immunology and Metabolic Bone Diseases, Medical University of Bialystok, Bialystok, Poland.
- 700 1_
- $a Montero-Errasquín, Beatriz $u Department of Geriatrics, University Hospital Ramón y Cajal, Madrid, Spain.
- 700 1_
- $a Topinková, Eva $u Department of Geriatrics and Gerontology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Tsekoura, Maria $u Department of Physical Therapy, School of Health and Welfare, Technological Institute of Western Greece, Aigio, Greece.
- 700 1_
- $a Reginster, Jean-Yves $u World Health Organization Collaborating Center for Public Health Aspects of Musculoskeletal Health and Ageing, Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium.
- 700 1_
- $a Bruyère, Olivier $u World Health Organization Collaborating Center for Public Health Aspects of Musculoskeletal Health and Ageing, Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium.
- 773 0_
- $w MED00180950 $t PloS one $x 1932-6203 $g Roč. 14, č. 4 (2019), s. e0216065
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31034498 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200518132628 $b ABA008
- 999 __
- $a ok $b bmc $g 1525270 $s 1096468
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 14 $c 4 $d e0216065 $e 20190429 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
- GRA __
- $a MC_U147585819 $p Medical Research Council $2 United Kingdom
- GRA __
- $a MC_UP_A620_1014 $p Medical Research Council $2 United Kingdom
- GRA __
- $a MC_UU_12011/1 $p Medical Research Council $2 United Kingdom
- GRA __
- $a G0400491 $p Medical Research Council $2 United Kingdom
- GRA __
- $a MC_U147585824 $p Medical Research Council $2 United Kingdom
- LZP __
- $a Pubmed-20200511